n Cardiovascular Journal of South Africa - Lipitor reduces total cardiovascular events in patients with type 2 diabetes : drug trends in cardiology
|Article Title||Lipitor reduces total cardiovascular events in patients with type 2 diabetes : drug trends in cardiology|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||May 2004|
|Pages||147 - 148|
Extracted from text ... Lipitor reduces total cardiovascular events in patients with type 2 diabetes Patients with type 2 diabetes taking Pfizer's cholesterol-lowering medicine Lipitor(r) (atorvastatin calcium) had a clinically relevant reduction in the incidence of cardiovascular events, according to results of a subgroup analysis of patients with type 2 diabetes from the three-year Anglo-Scandinavian Cardiac Outcomes Trial: Lipid-Lowering Arm (ASCOT-LLA), presented at the American College of Cardiology recently. The data are from 2 532 study subjects with type 2 diabetes, high blood pressure and high cholesterol, who showed a 23% reduction in the number of total cardiovascular events, such as a heart attack or ..
Article metrics loading...